Search

Objectives

In 2007, Taiwan began conducting health technology assessments (HTA) to support the National Health Insurance Administration (NHIA) in its reimbursement decisions for drugs, medical devices, and medical services.

Methods

In this study, the development, missions, and procedures of the implementation of HTA in Taiwan are briefly introduced. Moreover, the value of HTA is examined by reviewing the outcomes and impacts of recent HTA-related research projects, which are classified into five categories: (i) pharmaceutical products, (ii) medical procedures, (iii) medical devices, (iv) health policy, and (v) social care.

Results

Overall, the 10-year implementation of HTA has not only supported the government's decision making but also enhanced patient care. Furthermore, patient evidence has been highlighted, and patient care pathways have been transformed through patient involvement in HTA.

Conclusions

In conclusion, HTA's value has been determined by both government and social aspects in Taiwan.

Search Results

Refine search

Refine search

Actions for selected content:

1 results

Outcomes and Impacts of 10-Year HTA Implementation in Taiwan

Search Results

Refine search

Refine search

Actions for selected content:

Save Search

1 results

Outcomes and Impacts of 10-Year HTA Implementation in Taiwan